These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 10941627

  • 21. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
    Szumlinski KK, Frys KA, Kalivas PW.
    Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
    [Abstract] [Full Text] [Related]

  • 22. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K, Davids E, Tarazi FI, Baldessarini RJ.
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [Abstract] [Full Text] [Related]

  • 23. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B, Naylor RJ.
    Therapie; 1991 Apr; 46(6):437-44. PubMed ID: 1840228
    [Abstract] [Full Text] [Related]

  • 24. The use of the 5-HT3-receptor antagonist ondansetron for the treatment of postcardiotomy delirium.
    Bayindir O, Akpinar B, Can E, Güden M, Sönmez B, Demiroğlu C.
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):288-92. PubMed ID: 10890483
    [Abstract] [Full Text] [Related]

  • 25. Effect of ondansetron and ICS 205-930 on radiation-induced hypothermia in rats.
    Kandasamy SB.
    Radiat Res; 1997 Jun; 147(6):741-6. PubMed ID: 9189174
    [Abstract] [Full Text] [Related]

  • 26. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR, Joyner CM, Ellinwood EH.
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [Abstract] [Full Text] [Related]

  • 27. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB.
    Therapie; 1991 Mar; 46(6):431-5. PubMed ID: 1840227
    [Abstract] [Full Text] [Related]

  • 28. The selective 5-HT3 receptor antagonist, ondansetron, augments the anorectic effect of d-amphetamine in nondeprived rats.
    Cooper SJ, Greenwood SE, Gilbert DB.
    Pharmacol Biochem Behav; 1993 Jul; 45(3):589-92. PubMed ID: 8332620
    [Abstract] [Full Text] [Related]

  • 29. Effect of intra-tegmental microinjections of 5-HT1B receptor ligands on the amphetamine-induced locomotor hyperactivity in rats.
    Papla I, Filip M, Przegaliński E.
    Pol J Pharmacol; 2002 Jul; 54(4):351-7. PubMed ID: 12523488
    [Abstract] [Full Text] [Related]

  • 30. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP, Eliashar S, Belmaker RH, Ben-Uriah Y, Yehuda S.
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [Abstract] [Full Text] [Related]

  • 31. The role of serotonin in ephedrine-induced stereotypy and hypermotility.
    Malec D, Langwiński R, Kruszewska A.
    Arch Immunol Ther Exp (Warsz); 1976 Jun; 24(6):829-36. PubMed ID: 138404
    [Abstract] [Full Text] [Related]

  • 32. Dorsal hindbrain 5-HT3 receptors participate in control of meal size and mediate CCK-induced satiation.
    Hayes MR, Covasa M.
    Brain Res; 2006 Aug 04; 1103(1):99-107. PubMed ID: 16793030
    [Abstract] [Full Text] [Related]

  • 33. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR, Savastano DM, Covasa M.
    Physiol Behav; 2004 Sep 30; 82(4):663-9. PubMed ID: 15327914
    [Abstract] [Full Text] [Related]

  • 34. 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
    Kankaanpää A, Meririnne E, Seppälä T.
    Psychopharmacology (Berl); 2002 Feb 30; 159(4):341-50. PubMed ID: 11823886
    [Abstract] [Full Text] [Related]

  • 35. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM, Jantos H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May 15; 32(4):940-7. PubMed ID: 18295951
    [Abstract] [Full Text] [Related]

  • 36. Antagonism of behavioral effects of electroconvulsive shock but not those of desipramine by the selective 5-HT-3 receptor antagonist, ondansetron.
    Kostowski W, Płaźnik A, Nazar M, Jessa M.
    Pol J Pharmacol; 1995 May 15; 47(2):193-5. PubMed ID: 8688895
    [Abstract] [Full Text] [Related]

  • 37. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.
    Dogrul A, Ossipov MH, Porreca F.
    Brain Res; 2009 Jul 14; 1280():52-9. PubMed ID: 19427839
    [Abstract] [Full Text] [Related]

  • 38. Gastric distension enhances CCK-induced Fos-like immunoreactivity in the dorsal hindbrain by activating 5-HT3 receptors.
    Hayes MR, Covasa M.
    Brain Res; 2006 May 09; 1088(1):120-30. PubMed ID: 16630589
    [Abstract] [Full Text] [Related]

  • 39. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA.
    Eur J Pharmacol; 2005 Mar 21; 511(1):9-19. PubMed ID: 15777774
    [Abstract] [Full Text] [Related]

  • 40. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
    Liu W, Thielen RJ, McBride WJ.
    Pharmacol Biochem Behav; 2006 Jun 21; 84(2):370-7. PubMed ID: 16828150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.